|
New obesity drug shows stunning rate of weight loss in pilot study. |
 |
 |
|
New Scientist: Zafgen, a start-up drug company in Cambridge, Massachusetts, has announced that its first human test of a drug named ZGN-433 caused 24 obese women to lose, on average, a kilogram a week for a month – with no harmful side effects. The trial could not be extended past a month without initial safety tests at a range of doses – which was the purpose of this trial. The detailed results will be reported next week at a conference on obesity in Keystone, Colorado.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
